
ReAlta Life Sciences
Developer of immunomodulatory therapeutics designed for the treatment of acute inflammatory and rare diseases. The company utilizes engineered peptides derived from a viral capsid protein to simultane...
Valuation
$190M
Latest known
Share Price
N/A
Total Raised
$115.4M
Last Round
N/A